Product image of Linezolid Krka (Linezolid) supplied by GNH India

Linezolid Krka

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Krka (Linezolid)

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone presented as an injection for intravenous use. It treats serious Gram‑positive bacterial infections, including MRSA and VRE, in hospitalized patients.

GNH India supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is indicated for infections caused by Gram‑positive bacteria and is used in hospital settings for serious resistant infections.

  • Complicated skin and soft tissue infections: provides bacterial eradication and clinical cure.
  • Hospital‑acquired or ventilator‑associated pneumonia: improves respiratory outcomes and reduces mortality.
  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: achieves rapid bacterial clearance.
  • Vancomycin‑resistant Enterococcus (VRE) infections: offers an effective alternative when other agents fail.

How It Works

  • Linezolid binds to the 50S subunit of bacterial ribosomes, preventing the formation of the initiation complex for protein synthesis. This inhibition halts bacterial growth by blocking translation, leading to a bacteriostatic effect against susceptible Gram‑positive organisms.

Side Effects

Linezolid may cause a range of adverse reactions that clinicians monitor during therapy.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools, often self‑limiting.
  • Headache: transient cranial discomfort.
  • Thrombocytopenia: reduced platelet count, usually reversible.

Serious or Rare Side Effects

  • Myelosuppression: severe anemia or neutropenia requiring hematologic evaluation.
  • Peripheral neuropathy: sensory changes that may become irreversible.
  • Serotonin syndrome: risk when combined with serotonergic agents, presenting with agitation, hyperreflexia, and fever.

Precautions & Warnings

Before initiating Linezolid, clinicians should assess patient history and laboratory parameters.

  • Renal impairment: adjust monitoring as drug is partially excreted renally.
  • Hepatic dysfunction: evaluate liver enzymes regularly.
  • Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome.
  • Prolonged therapy (>14 days): monitor blood counts for myelosuppression.
  • Hypersensitivity: discontinue if rash or anaphylaxis occurs.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: may precipitate serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis.

Moderate Interactions (Monitor Closely)

  • Rifampicin: may reduce linezolid plasma concentrations.
  • Warfarin: potential for increased anticoagulant effect; monitor INR.
  • Ethanol: may enhance central nervous system depression; advise caution.

Frequently Asked Questions

Linezolid Krka is an intravenous oxazolidinone antibiotic indicated for the treatment of serious Gram‑positive bacterial infections, including complicated skin and soft‑tissue infections, hospital‑acquired or ventilator‑associated pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA) or vancomycin‑resistant Enterococcus (VRE).

Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex required for translation. This action stops bacterial growth, providing a bacteriostatic effect against susceptible Gram‑positive organisms.

The dose of Linezolid Krka is determined by the prescribing clinician based on the type and severity of infection, patient weight, renal and hepatic function, and local antimicrobial guidelines. No fixed regimen is provided here.

Safety data for linezolid during pregnancy and lactation are limited. Use is generally reserved for situations where the potential benefit outweighs potential risks to the fetus or infant, and the decision should be made by the treating physician.

To order Linezolid Krka, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Linezolid offers oral and intravenous options and is active against MRSA strains resistant to beta‑lactams and glycopeptides. Compared with vancomycin, linezolid provides similar efficacy for skin and lung infections but may have a more favorable tissue penetration profile, though it carries a distinct safety profile that requires monitoring.

Linezolid Krka for injection should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the product in its original packaging until use to maintain stability.

Linezolid Krka is administered intravenously by a healthcare professional. The injection is given over a short period, typically as a slow infusion, following the dosing instructions provided by the prescriber.

Serious risks include myelosuppression (especially thrombocytopenia, anemia, neutropenia), peripheral neuropathy, and serotonin syndrome when combined with serotonergic drugs. Patients should be monitored regularly for blood‑count changes and neurological symptoms.

Linezolid Krka should be avoided in patients with known hypersensitivity to linezolid or other oxazolidinones, in those currently receiving monoamine oxidase inhibitors, and in individuals where the risk of serotonin syndrome cannot be mitigated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT